touchPODCAST

Advancing outcomes in CP-CML: Guideline-directed approaches to treatment decision-making, monitoring and toxicity management

20 Mar 2026

Contributed by Lukas

touchPANEL DISCUSSION for touchHAEMATOLOGY and touchONCOLOGY Listen to leading experts discuss guideline-directed strategies for mutational analysis ...

Targeting brain metastases in advanced NSCLC: The emerging impact of ADCs

05 Mar 2026

Contributed by Lukas

touchPANEL DISCUSSION for touchONCOLOGY and touchRESPIRATORY   Listen to leading experts discuss the role of antibody–drug conjugates (ADCs) in NSC...

The bare necessities of hyperphagia in Prader–Willi syndrome: Expert insights on recognition and management

27 Feb 2026

Contributed by Lukas

touchEXPERT FOCUS for touchENDOCRINOLOGY Listen to a series of short interviews with paediatric endocrinologist Dr Ashley Shoemaker as she discusses t...

Evolving paradigms in PNH management: Interpreting the latest data

25 Feb 2026

Contributed by Lukas

touchPANEL DISCUSSION for touchHAEMATOLOGY and touchONCOLOGY Listen to a panel of leading experts as they explore the latest advances in PNH pathophys...

Diagnosis, multidisciplinary monitoring and individualized management in LOPD

21 Jan 2026

Contributed by Lukas

touchCASES for touchNEUROLOGY, touchCARDIO, touchENDOCRINOLOGY and touchRESPIRATORY Listen to two experts as they discuss three cases illustrating the...

Unlocking the possibilities of BCMA-directed therapies in RRMM: Latest perspectives from IMS and ASH 2025

21 Jan 2026

Contributed by Lukas

touchCONGRESS for touchHAEMATOLOGY and touchONCOLOGY Listen to multiple myeloma expert Dr Rakesh Popat review key data for BCMA-targeting agents in th...

Evolving strategies in low-grade serous ovarian cancer: Applying the evidence to optimize patient care

15 Jan 2026

Contributed by Lukas

touchEXPERT FOCUS for touchONCOLOGY Listen to insights from Dr Kathleen Moore on the pathophysiology and molecular features of low-grade serous ovaria...

Overcoming EGFR-TKI resistance: Emerging therapies and biomarker strategies in NSCLC

05 Jan 2026

Contributed by Lukas

touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY Module 1: Beyond EGFR: Addressing actionable drug resistance mechanisms In this modu...

Managing cytopenias: The path to transfusion independence for patients with myelofibrosis

05 Dec 2025

Contributed by Lukas

touchIN CONVERSATION for touchHAEMATOLOGY The presence of anaemia and/or thrombocytopenia complicates the management of patients with myelofibrosis (M...

Innovations and advances in CML: Focus on navigating early-line options and maintaining quality of life

20 Nov 2025

Contributed by Lukas

touchEXPERT FOCUS for touchHAEMATOLOGY and touchONCOLOGY Listen to a series of short interviews with three leading experts who provide their insights...

Breakthroughs in treating NSCLC: Targeting KRAS

19 Nov 2025

Contributed by Lukas

touchTALKS for touchONCOLOGY Listen to Dr Christine Bestvina, as she evaluates the latest data on KRAS mutations in NSCLC and explores how emerging ev...

HER2 in focus: Advancing treatment for biliary tract and gastroesophageal cancers

18 Nov 2025

Contributed by Lukas

touchEXPERT FOCUS for touchONCOLOGY Listen to a series of short interviews with four leading experts as they discuss the role of HER2 as a targetable ...

Delivering state-of-the-art care for GEP-NETs: Evidence-based strategies for PRRT

18 Nov 2025

Contributed by Lukas

touchPANEL DISCUSSION for touchONCOLOGY and touchENDOCRINOLOGY Listen to a panel of leading experts discuss the optimal management of gastroenteropanc...

Overcoming EGFR-TKI resistance: Emerging therapies and biomarker strategies in NSCLC

17 Nov 2025

Contributed by Lukas

touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY Module 1: Beyond EGFR: Addressing actionable drug resistance mechanisms In this modu...

Eyeing better outcomes in diabetic macular oedema: Clinical insights on the evolving role of corticosteroids

30 Oct 2025

Contributed by Lukas

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of interviews with two medical retina specialists and a biomarker expert who will provide ...

Diagnosis and treatment of patients with Lennox–Gastaut syndrome

23 Oct 2025

Contributed by Lukas

touchPANEL DISCUSSION for touchNEUROLOGY Listen to a panel of experts in epilepsy as they discuss how to promptly and accurately diagnose and manage L...

Updates in hypertrophic cardiomyopathy care: Bridging the current treatment gaps with emerging novel therapies

20 Oct 2025

Contributed by Lukas

touchEXPERT FOCUS for touchCARDIO Listen to short interviews with two expert cardiologists discussing the role of current and emerging therapeutic cla...

Overcoming EGFR-TKI resistance: Emerging therapies and biomarker strategies in NSCLC

20 Oct 2025

Contributed by Lukas

Module 1: Beyond EGFR: Addressing actionable drug resistance mechanisms touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY In this modu...

Staying ahead of the curve in HNSCC care: Refining the role of immunotherapy across disease stages

09 Oct 2025

Contributed by Lukas

touchEXPERT FOCUS for touchONCOLOGY Listen to insights from Prof. Jean-Pascal Machiels on optimizing the use of immunotherapy in patients with recurr...

FCS unmasked: Closing gaps in diagnosis, treatment and patient support

02 Oct 2025

Contributed by Lukas

touchIN CONVERSATION for touchCARDIOLOGY and touchENDOCRINOLOGY Listen to two experts as they discuss the diagnosis, treatment and how to support pati...

Achieving effective lifespan care in sickle cell disease: From recognizing the burden to novel therapeutics

01 Oct 2025

Contributed by Lukas

touchEXPERT FOCUS for touchHAEMATOLOGY Prof. Lucia de Franceschi, a leading expert in sickle cell disease, examines the clinical manifestations and bu...

Bridging diagnostic and therapeutic gaps in Fabry disease management

30 Sep 2025

Contributed by Lukas

touchEXPERT FOCUS for touchENDOCRINOLOGY, touchCARDIO and touchNEUROLOGY Listen to a series of short expert interviews on timely diagnosis and indivi...

Applying patient and disease characteristics to guide R/M NPC treatment

24 Sep 2025

Contributed by Lukas

touchCASES for touchONCOLOGY Listen to three experts as they discuss how patient and disease characteristics may inform treatment selection in recurre...

Therapeutic advances in RRMM: What is the latest on practical application of BCMA-directed therapies?

10 Sep 2025

Contributed by Lukas

touchEXPERT FOCUS for touchHAEMATOLOGY and touchONCOLOGY Listen to a series of short expert interviews on the role of B-cell maturation antigen (BCMA)...

Phacoemulsification in cataract surgery: Evolving options to optimize refractive outcomes

10 Sep 2025

Contributed by Lukas

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of short interviews with leading experts on phacoemulsification in cataract surgery. The f...

Stargardt disease: Improving awareness, diagnosis and patient support

27 Aug 2025

Contributed by Lukas

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of interviews with Prof. Elias Traboulsi on the clinical presentation, diagnosis and manag...

Mastering DKA management: From pathophysiology to prevention and ketone monitoring strategies

26 Aug 2025

Contributed by Lukas

touchTALKS for touchENDOCRINOLOGY  Listen to Prof. Jennifer Sherr, as she discusses key updates on the prevention and management of DKA. The discuss...

A case-based discussion on PAH: Optimizing early detection, risk stratification and treatment decision-making

21 Aug 2025

Contributed by Lukas

touchCASES for touchRESPIRATORY and touchCARDIO This touchCASES activity presents expert-led discussions exploring three clinical cases of pulmonary a...

Continuous glucose monitoring for cardiovascular risk reduction: The next frontier in preventive care

20 Aug 2025

Contributed by Lukas

touchEXPERT FOCUS for touchCARDIO and touchENDOCRINOLOGY Listen to two experts discuss how continuous glucose monitoring (CGM) can help identify and m...

HER2 as a targetable biomarker in gastrointestinal oncology

19 Aug 2025

Contributed by Lukas

touchEXPERT FOCUS for touchONCOLOGY Listen to a series of short interviews with three leading experts as they discuss the use of HER2 as a targetable ...

Navigating the evolving role of immunotherapy in advanced endometrial carcinoma

31 Jul 2025

Contributed by Lukas

touchPANEL DISCUSSION for touchONCOLOGY Listen to three leading international experts in gynaecological oncology as they discuss how immunotherapy is ...

Focus on treatment advances for ATTRv: A heterogeneous, highly debilitating and ultimately fatal disease

29 Jul 2025

Contributed by Lukas

touchEXPERT FOCUS for touchNEUROLOGY and touchCARDIO Listen to Dr Chafic Karam share expert insights on diagnosing and managing ATTRv amyloidosis. In ...

Navigating the treatment of RRMM with BCMA-directed therapies: Updates from COMy, ASCO and EHA 2025

09 Jul 2025

Contributed by Lukas

touchCONGRESS for touchHAEMATOLOGY and touchONCOLOGY Listen to multiple myeloma expert Prof. Philippe Moreau review key data for BCMA-targeting agents...

Advancing care for patients with infantile haemangiomas: Timing is key

07 Jul 2025

Contributed by Lukas

touchEXPERT FOCUS for touchDERMATOLOGY Listen to Prof. Ilona Frieden share expert insights on the clinical management of infantile haemangiomas, with...

Incorporating ADCs into the treatment of mBC: Practical considerations for the community oncologist

26 Jun 2025

Contributed by Lukas

touchIN CONVERSATION for touchONCOLOGY Listen to two oncologists discuss the incorporation of antibody–drug conjugates (ADCs) into the treatment of ...

Multidisciplinary management of TNBC Integrating immunotherapies for early and metastatic disease

25 Jun 2025

Contributed by Lukas

touchEXPERT FOCUS for touchONCOLOGY Listen to a series of short interviews with three leading experts discussing the application of immunotherapy in t...

Applying immunotherapy in clinical practice for patients with early-stage NSCLC

23 Jun 2025

Contributed by Lukas

touchEXPERT FOCUS for touchRESPIRATORY Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cance...

Applying immunotherapy in clinical practice for patients with early-stage NSCLC

23 Jun 2025

Contributed by Lukas

touchEXPERT FOCUS for touchONCOLOGY Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (...

Towards personalized care for people living with HIV: Supporting open dialogue and informed treatment choices

19 Jun 2025

Contributed by Lukas

NEW touchCASES for touchINFECTIOUS DISEASES Listen to  Prof. José Arribas, a leading HIV expert, and Ms Harriet Langanke, a journalist and HIV activ...

RET-positive NSCLC: Translating insights into targeted approaches

15 May 2025

Contributed by Lukas

touchFOCUS for touchRESPIRATORY In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved R...

RET-positive NSCLC: Translating insights into targeted approaches

15 May 2025

Contributed by Lukas

touchFOCUS for touchONCOLOGY In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET ...

Advances in dry eye disease: From diagnosis to new treatment targets

08 May 2025

Contributed by Lukas

touchEXPERT FOCUS touchOPHTHALMOLOGY Listen to Dr Laura Periman share expert insights on dry eye disease. In this episode, she explores the pathophysi...

Recent advances in the care of patients with geographic atrophy: Bringing new and emerging therapies into focus

06 May 2025

Contributed by Lukas

touchIN CONVERSATION for touchOPHTHALMOLOGY Listen to two experts in geographic atrophy (GA) discuss recent advances in the care of patients. They exp...

The potential of BTKi therapies in delaying MS progression

30 Apr 2025

Contributed by Lukas

touchEXPERT FOCUS for touchNEUROLOGY Join Prof. Montalban as he shares expert insights into the pathophysiology of progressive MS and the rationale fo...

Reducing burden of disease in gMG: Exploring the role of FcRn inhibitors

30 Apr 2025

Contributed by Lukas

touchPANEL DISCUSSION for touchNEUROLOGY Listen to two expert neurologists and a neurology nurse as they explore the role of neonatal Fc receptor (FcR...

MDT perspectives on why and how to implement continuous glucose monitoring in T2D

30 Apr 2025

Contributed by Lukas

Listen to key experts from a multidisciplinary team review and discuss why and how to implement continuous glucose monitoring in T2D. The multidiscipl...

MDT perspectives on evolving options for insulin therapy

30 Apr 2025

Contributed by Lukas

Listen to key experts from a multidisciplinary team review and discuss evolving options for insulin therapy.  The multidisciplinary team Endocrinolo...

MDT perspectives on understanding clinical inertia in T2D

30 Apr 2025

Contributed by Lukas

Listen to key experts from a multidisciplinary team review and discuss clinical inertia in T2D. The multidisciplinary team Endocrinologist: Prof Tina...

Navigating the clinical impact of TROP2-targeting in NSCLC

24 Apr 2025

Contributed by Lukas

touchSYMPOSIUM for touchRESPIRATORY Listen to this touchSYMPOSIUM recorded live in March 2025 at the The European Lung Cancer Congress in Paris, Fran...

Navigating the clinical impact of TROP2-targeting in NSCLC

24 Apr 2025

Contributed by Lukas

touchSYMPOSIUM for touchONCOLOGY Listen to this touchSYMPOSIUM recorded live in March 2025 at the The European Lung Cancer Congress in Paris, France. ...

Integrating treatment advances for alpha-mannosidosis into effective MDT care - touchNEUROLOGY

11 Apr 2025

Contributed by Lukas

touchPANEL DISCUSSION for touchNEUROLOGY Listen to a panel of world-leading experts in lysosomal storage disorders  explore treatment needs along the...

Integrating treatment advances for alpha-mannosidosis into effective MDT care - touchENDOCRINOLOGY

11 Apr 2025

Contributed by Lukas

touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to a panel of world-leading experts in lysosomal storage disorders  explore treatment needs along...

The evolving standard of care for advanced/recurrent endometrial cancer: A practice-focused discussion of immunotherapy

07 Apr 2025

Contributed by Lukas

touchIN CONVERSATION for touchONCOLOGY Listen to two expert gynaecologic oncology specialists discuss the evolving role of immunotherapy in the treatm...

Tailoring treatment in myelofibrosis: Addressing anaemia and thrombocytopenia

02 Apr 2025

Contributed by Lukas

touchPANEL DISCUSSION for touchHAEMATOLOGY Listen to three experts as they explore the burden of myelofibrosis and anaemia and/or thrombocytopenia, di...

Video 3: MDT perspectives on identifying and managing key ADC treatment toxicities in patients with metastatic breast cancer

31 Mar 2025

Contributed by Lukas

Listen to key experts from a multidisciplinary team consider the strategies to avoid, mitigate, identify and effectively manage side effects associate...

Video 2: MDT perspectives on communicating ADC treatment toxicities to patients with metastatic breast cancer

31 Mar 2025

Contributed by Lukas

Listen to key experts from a multidisciplinary team discuss effective strategies for communicating the potential side effects associated with ADC trea...

Video 1: MDT perspectives on the safety profiles of current and emerging ADCs in metastatic breast cancer

31 Mar 2025

Contributed by Lukas

Listen to key experts from a multidisciplinary team review and discuss the safety profiles of current and emerging ADCs in patients with metastatic br...

Precision in practice: Adopting emerging therapies for retinal diseases to reduce burden of disease

31 Mar 2025

Contributed by Lukas

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to retina specialist Prof. Peter Kaiser answer a series of questions on the current clinical landscape...

Expanding horizons for patients with Pompe disease: Using data to guide clinical practice

18 Mar 2025

Contributed by Lukas

touchCONGRESS for touchCARDIO Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options f...

Expanding horizons for patients with Pompe disease: Using data to guide clinical practice

18 Mar 2025

Contributed by Lukas

touchCONGRESS for touchENDOCRINOLOGY Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment op...

Expanding horizons for patients with Pompe disease: Using data to guide clinical practice

18 Mar 2025

Contributed by Lukas

touchCONGRESS for touchNEUROLOGY Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment option...

Expanding horizons for patients with Pompe disease Using data to guide clinical practice

18 Mar 2025

Contributed by Lukas

touchCONGRESS for touchRESPIRATORY Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment opti...

MDT perspectives on the importance of patient engagement in PARPi use - Video 3

06 Mar 2025

Contributed by Lukas

touchMDT for touchONCOLOGY Listen to experts Dr Alicia Morgans, Dr Grace Cullen, and patient advocate, Mr Tony Collier, discuss the importance and pra...

MDT perspectives on understanding precision medicine to guide PARPi use in mCRPC - Video 2

06 Mar 2025

Contributed by Lukas

touchMDT for touchONCOLOGY   Somatic and germline testing are key in managing metastatic castration-resistant prostate cancer (mCRPC). Listen as Pro...

MDT perspectives on unlocking the data on PARPi to support shared decision-making in mCRPC - Video 1

06 Mar 2025

Contributed by Lukas

touchMDT for touchONCOLOGY MDT perspectives on unlocking the data on PARPi to support shared decision-making in mCRPC Experts Dr Alicia Morgans and Dr...

The next frontier in managing obesity and T2D: The role of novel combinations for touchCARDIO

27 Feb 2025

Contributed by Lukas

touchEXPERT OPINIONS for touchCARDIO Listen to three experts discuss the rationale behind glucagon-like peptide-1 (GLP-1)-based combination therapies...

The next frontier in managing obesity and T2D: The role of novel combinations for touchENDOCRINOLOGY

27 Feb 2025

Contributed by Lukas

touchEXPERT OPINIONS for touchENDOCRINOLOGY Listen to three experts discuss the rationale behind glucagon-like peptide-1 (GLP-1)-based combination th...

From clinical trials to clinical practice: Applying CDK4/6 inhibitors in HR+/HER2– early breast cancer

21 Feb 2025

Contributed by Lukas

touchEXPERT OPINIONS for touchONCOLOGY Listen to three experts in breast cancer as they provide insights into the current guideline recommendations fo...

Cervical cancer prevention and beyond: Optimizing HPV vaccine uptake in all eligible individuals

20 Feb 2025

Contributed by Lukas

touchIN CONVERSATION for touchONCOLOGY Listen to a paediatrician specializing in adolescent medicine and a general practitioner specializing in sexua...

Cervical cancer prevention and beyond: Optimizing HPV vaccine uptake in all eligible individuals

20 Feb 2025

Contributed by Lukas

touchIN CONVERSATION for touchINFECTIOUS DISEASES Listen to a paediatrician specializing in adolescent medicine and a general practitioner specializi...

Looking to the future in the treatment of steroid-refractory chronic GvHD

18 Feb 2025

Contributed by Lukas

touchFOCUS for touchONCOLOGY In this concise interview, Dr Corey Cutler discusses unmet needs in steroid-refractory chronic GvHD and how they may be a...

Looking to the future in the treatment of steroid-refractory chronic GvHD

18 Feb 2025

Contributed by Lukas

touchFOCUS for touchHAEMATOLOGY In this concise interview, Dr Corey Cutler discusses unmet needs in steroid-refractory chronic GvHD and how they may b...

Updates in BCMA-directed therapies in multiple myeloma from ASH 2024

06 Feb 2025

Contributed by Lukas

touchCONGRESS for ONCOLOGY Multiple myeloma expert Prof. Katja Weisel summarizes key data for BCMA-targeted agents in multiple myeloma presented at th...

Updates in BCMA-directed therapies in multiple myeloma from ASH 2024

06 Feb 2025

Contributed by Lukas

touchCONGRESS for touchHAEMATOLOGY Multiple myeloma expert Prof. Katja Weisel summarizes key data for BCMA-targeted agents in multiple myeloma present...

RAS mutations and personalized cancer care: Targeting the future

30 Jan 2025

Contributed by Lukas

touchEXPERT OPINIONS for touchONCOLOGY Listen to a medical oncologist, a pancreatic cancer specialist and a lung cancer specialist discuss the role of...

What’s new in primary ITP? Key updates from ASH 2024

29 Jan 2025

Contributed by Lukas

touchPANEL DISCUSSION for touchONCOLOGY Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emer...

What’s new in primary ITP? Key updates from ASH 2024

29 Jan 2025

Contributed by Lukas

touchPANEL DISCUSSION for touchHAEMATOLOGY Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, e...

Focused insights: Data implications of ADCs in NSCLC treatment

24 Jan 2025

Contributed by Lukas

touchFOCUS for touchRESPIRATORY Listen to Prof. Céline Mascaux, an expert in thoracic oncology, answer a series of questions on the latest efficacy a...

Focused insights: Data implications of ADCs in NSCLC treatment

24 Jan 2025

Contributed by Lukas

touchFOCUS for touchONCOLOGY Listen to Prof. Céline Mascaux, an expert in thoracic oncology, answer a series of questions on the latest efficacy and ...

Collaboration in chronic ITP: Improving quality of life and patient outcomes - touchSYMPOSIUM for touchONCOLOGY

21 Jan 2025

Contributed by Lukas

touchSYMPOSIUM for touchHAEMATOLOGY Listen to this touchSYMPOSIUM recorded live in December 2024 preceding the 66th American Society of Hematology Ann...

Collaboration in chronic ITP: Improving quality of life and patient outcomes - touchSYMPOSIUM for touchHAEMATOLOGY

21 Jan 2025

Contributed by Lukas

touchSYMPOSIUM for touchHAEMATOLOGY Listen to this touchSYMPOSIUM recorded live in December 2024 preceding the 66th American Society of Hematology Ann...

Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life - touchONCOLOGY

06 Jan 2025

Contributed by Lukas

touchEXPERT FOCUS for touchONCOLOGY Listen to three experts provide insights into the optimal management of neurofibromatosis type 1 (NF1) in paediatr...

Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life - touchNEUROLOGY

06 Jan 2025

Contributed by Lukas

touchEXPERT FOCUS for touchNEUROLOGY Listen to three experts provide insights into the optimal management of neurofibromatosis type 1 (NF1) in paediat...

Advancing the treatment of muscle-invasive bladder cancer: Updates on immunotherapy in the perioperative setting

19 Dec 2024

Contributed by Lukas

touchEXPERT OPINIONS for touchONCOLOGY Listen to an oncologist, urologist and oncology nurse highlight the key data for immunotherapy in the perioper...

Navigating treatment choices in high-risk early-stage melanoma - touchDERMATOLOGY

17 Dec 2024

Contributed by Lukas

touchEXPERT OPINIONS for touchDERMATOLOGY Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate ...

Navigating treatment choices in high-risk early-stage melanoma - touchONCOLOGY

17 Dec 2024

Contributed by Lukas

touchEXPERT OPINIONS for touchONCOLOGY  Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate t...

Advances in IOL technology and power calculations: Updates and innovations from 2024

04 Dec 2024

Contributed by Lukas

touchFOCUS for touchOPHTHALMOLOGY Listen to Dr John Ladas, an expert in cataract surgery, as he answers a series of questions on intraocular lens powe...

Supporting healing in epidermolysis bullosa: Innovations and new directions for care

27 Nov 2024

Contributed by Lukas

touchFOCUS for touchDERMATOLOGY Listen to Prof. Amy Paller as she answers a series of questions on the key features of epidermolysis bullosa, includi...

Primary biliary cholangitis: Appraising the changing therapeutic landscape

14 Nov 2024

Contributed by Lukas

touchEXPERT OPINIONS for touchIMMUNOLOGY Listen to a leading expert in hepatology as they explore the current and future management of primary biliary...

Primary biliary cholangitis: Appraising the changing therapeutic landscape

14 Nov 2024

Contributed by Lukas

touchEXPERT OPINIONS for touchENDOCRINOLOGY Listen to a leading expert in hepatology as they explore the current and future management of primary bili...

touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4

14 Nov 2024

Contributed by Lukas

touchMDT for touchONCOLOGY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary t...

touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 3

14 Nov 2024

Contributed by Lukas

touchMDT for touchONCOLOGY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary t...

touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4

14 Nov 2024

Contributed by Lukas

touchMDT for touchRESPIRATORY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinar...

touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 3

14 Nov 2024

Contributed by Lukas

touchMDT for touchRESPIRATORY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinar...

touchMDT for touchRESPIRATORY - What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung cancer (LS-SCLC)?

13 Nov 2024

Contributed by Lukas

touchMDT for touchRESPIRATORY What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell l...

touchMDT for touchRESPIRATORY - What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)?

13 Nov 2024

Contributed by Lukas

touchMDT for touchRESPIRATORY What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (...

touchMDT for touchRESPIRATORY - What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)?

13 Nov 2024

Contributed by Lukas

touchMDT for touchRESPIRATORY What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)? L...

touchMDT for touchONCOLOGY - What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung cancer (LS-SCLC)?

13 Nov 2024

Contributed by Lukas

touchMDT for touchONCOLOGY What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung...

touchMDT for touchONCOLOGY - What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)?

13 Nov 2024

Contributed by Lukas

touchMDT for touchONCOLOGY What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS...

touchMDT for touchONCOLOGY - What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)?

13 Nov 2024

Contributed by Lukas

touchMDT for touchONCOLOGY What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)? List...